MD Anderson Cancer Center Department of Lymphoma & Myeloma
Houston, Texas, United States
Medical clinic in Houston, Texas
1515 Holcombe Blvd, Houston, TX 77030
About MD Anderson Cancer Center Department of Lymphoma & Myeloma
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MD Anderson Cancer Center Department of Lymphoma & Myeloma
During the past decade, MD Anderson Cancer Center Department of Lymphoma & Myeloma conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
1997-04-01
2012-04-01
Completed
428
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
1999-04-01
2011-07-01
Completed
4,590
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
1999-04-01
2011-02-01
Completed
605
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson Cancer Center Department of Lymphoma & Myeloma"
#1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at MD Anderson Cancer Center Department of Lymphoma & Myeloma
According to Clinical.Site data, the most researched conditions in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" are
"Diffuse Large B-Cell Lymphoma" (1 trials) and "Lymphoma, B-Cell" (1 trials). Many other conditions were trialed in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" in a lesser frequency.
Clinical Trials Intervention Types at MD Anderson Cancer Center Department of Lymphoma & Myeloma
Most popular intervention types in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Obinutuzumab" (1 trials), "Prednisone" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MD Anderson Cancer Center Department of Lymphoma & Myeloma
The vast majority of trials in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" are
2 trials for "All" genders.
Clinical Trials Status at MD Anderson Cancer Center Department of Lymphoma & Myeloma
Currently, there are NaN active trials in "MD Anderson Cancer Center Department of Lymphoma & Myeloma".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MD Anderson Cancer Center Department of Lymphoma & Myeloma,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MD Anderson Cancer Center Department of Lymphoma & Myeloma, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".